Clinical characteristics | Number of cases (%) |
---|
Age (y) |
≥ 65 | 160 (54.8) |
< 65 | 132 (45.2) |
Sex |
Male | 150 (51.4) |
Female | 142 (48.6) |
Clinical stage |
I | 150 (51.4) |
II | 72 (24.7) |
III | 51 (17.5) |
IV | 19 (6.5) |
T classification |
T1 | 88 (30.1) |
T2 | 164 (56.2) |
T3 | 24 (8.2) |
T4 | 16 (5.5) |
N classification |
N0 | 184 (63.0) |
N1 | 63 (21.6) |
N2 | 44 (15.1) |
N3 | 1 (0.3) |
Metastasis |
No | 273 (93.5) |
Yes | 19 (6.5) |
Expression of NCAPG |
Low expression | 128 (43.8) |
High expression | 164 (56.2) |
- T for extent of the primary tumor; N for involvement of lymph nodes
- T1: Tumor ≤ 3 cm; T2: Tumor > 3 but ≤ 5 cm or tumor involving visceral pleura, main bronchus (not carina), atelectasis to hilum; T3: Tumor > 5 but ≤ 7 cm or invading chest wall, pericardium, phrenic nerve or or separate tumor nodule(s) in the same lobe; T4: Tumor > 7 cm or tumor invading: mediastinum, diaphragm, heart, great vessels, recurrent laryngeal nerve, carina, trachea, esophagus, spine or tumor nodule(s) in a different ipsilateral lobe
- N0: No regional node metastasis; N1: Metastasis in ipsilateral pulmonary or hilar nodes; N2: Metastasis in ipsilateral mediastinal/subcarinal nodes; N3: Metastasis in contralateral mediastinal/hilar, or suprclavicular nodes